Trial Profile
Randomized Controlled Trial of Transarterial Embolization Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 May 2023
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary) ; Doxorubicin
- Indications Liver cancer
- Focus Therapeutic Use
- 13 May 2021 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2022.
- 18 Nov 2016 New trial record